diagnosed using tool has causal or contributing genetic variation in guideline Genetic Testing Blood Smear Hemoglobin Profile Assay Sickle Cell Thalassemia Hemolytic anemia, in which patients are compound or double heterozygous for both the sickle cell gene and a thalassemia gene. NCIT:C61237 Suggest update to description Sickle Cell-Thalassemia Suggest update to description in NCIT Beta Thalassemia Mutation HBB, GLU6VAL Recommendations for the Management of Sickle Cell Disease in South Africa National Guideline for the Control and Management of Sickle Cell Disease A Parental Guide to Managing Sickle Cell Disease Standards for Clinical Care of Adults with Sickle Cell Disease in the UK Sickle Cell Disease: The Clinical Care Guidelines of the Sickle Cell Unit Consensus Statement on the Care of Patients with Sickle Cell Disease in Canada Sickle Cell Disease in Children, Standards and Guidelines for Clinic Care Evidence-Based Management of Sickle Cell Disease Management of Children with Sickle Cell Disease in Europe: Current Situation and Future Perspectives Compound Heterozygous Sickle Cell Disease Structural and Quantitative Hemoglobinopathy